These results are in line with data previously published, in which it was shown that HMGA1 regulated several pro-tumoral processes in dedifferentiated and myxoid liposarcoma, including resistance to trabectedin treatment [26]. The gene discussed is HMGA1; the disease is myxoid liposarcoma.